by Kazeem Olalekan

The following are some of the latest important updates from the newly April 2014 release of the BNF and BNFc:


Interchangeability of oral mesalazine preparations - BNF & BNFc


Metoclopramide: risk of neurological adverse effects - BNFc


Risk of venous thromboembolism events (VTE) with combined hormonal contraceptives

There are others: Do look at the BNFand BNFc websites

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.